To determine whether FOSL1 plays a role in this process, we assessed the expression of key stemness‐associated markers, including SOX2, CD133, OCT4, and NANOG, in primary GBM cells stratified by MGMT promoter methylation status. The gene discussed is SOX2; the disease is glioblastoma.